OpenVSafe by OpenVAERS
Search V-safe

5B7-69328-67143

2 vaccinations 7 coded responses 24 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
305 / GA
Registered
2021-03-14
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-14
    Registered in v-safe
  3. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  4. 2021-03-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Therapeutic response unexpected — Feeling: Good
    Free text: In less than 18 hours after receiving my vaccine, I regained my full taste/smell that had been effected since 12-24-2020.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains
    Adult check-in
  7. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-20
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-03-27
    Survey response — day 14, dose 1
    MedDRA: Ageusia, Anosmia — Feeling: Good
    Free text: I lost my taste and smell 12/24/2020. After receiving my 1st vaccine, my taste and smell fully returned. It had been at 50% prior to receiving the vaccine. 5 days post vaccination, my taste and smell returned back to only being at 50%.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-03
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-03
    Survey response — day 0, dose 2
    MedDRA: Hypogeusia, Hyposmia, Pre-existing disease — Feeling: Good · Site: Pain
    Free text: Still have minimal taste/smell from Covid-19 on 12/24/2020
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  14. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-03
    Survey response — day 28, dose 2
    MedDRA: Hypogeusia, Hyposmia, Parosmia — Feeling: Good
    Free text: Diminished taste/smell; intermittent metallic taste and intermittent smell of cigarette smoke/ashes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-03
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Dyspepsia, Pain in extremity — Feeling: Good · Be unable to do your normal daily activities
    Free text: Pain of bottom and lateral left foot; bilateral ankle pain. Intermittent heart burn.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-10-02
    Survey response — 6 months, dose 2
    MedDRA: Ageusia, Anosmia, Brain fog, Inflammation, Memory impairment, Pain in extremity, Respiratory symptom — Feeling: Fair
    Free text: Still do not have taste or smell back; currently with upper respiratory symptoms, intermittent pain/inflammation to Lt foot/sole. I have periods of continued brain fog; inability to recall known information such as common words or phone number.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-04-05
    Survey response — 12 months, dose 2
    MedDRA: Balance disorder, COVID-19, Hypogeusia, Hyposmia, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Unsteadiness when picking up a leg over the past 3-4 months; not noted prior to COVID. Still have diminished taste/smell from Dec 2020. · Healthcare visit (other): Will have upcoming face-to-face visit with Neurology
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-05
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2022-04-12
  30. 2022-04-12
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-13Pfizer-BioNTech
22021-04-03Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-16

Systemic reaction (other): In less than 18 hours after receiving my vaccine, I regained my full taste/smell that had been effected since 12-24-2020.

Release 6 — day 14, dose 1

2021-03-27

Symptoms: I lost my taste and smell 12/24/2020. After receiving my 1st vaccine, my taste and smell fully returned. It had been at 50% prior to receiving the vaccine. 5 days post vaccination, my taste and smell returned back to only being at 50%.

Release 6 — day 0, dose 2

2021-04-03

Systemic reaction (other): Still have minimal taste/smell from Covid-19 on 12/24/2020

Release 8 — day 28, dose 2

2021-05-03

Symptoms: Diminished taste/smell; intermittent metallic taste and intermittent smell of cigarette smoke/ashes

Release 9 — 3 months, dose 2

2021-07-03

Symptoms: Pain of bottom and lateral left foot; bilateral ankle pain. Intermittent heart burn.

Release 9 — 6 months, dose 2

2021-10-02

Symptoms: Still do not have taste or smell back; currently with upper respiratory symptoms, intermittent pain/inflammation to Lt foot/sole. I have periods of continued brain fog; inability to recall known information such as common words or phone number.

Release 11 — 12 months, dose 2

2022-04-05

Symptoms: Unsteadiness when picking up a leg over the past 3-4 months; not noted prior to COVID. Still have diminished taste/smell from Dec 2020.
Healthcare visit (other): Will have upcoming face-to-face visit with Neurology

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAgeusia ✓ ✓ ✓
SDAnosmia ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDBalance disorder · · ✓
SDBrain fog · · ✓
SDCOVID-19 · · ✓
SDDyspepsia ✓ ✓ ✓
SDHypogeusia ✓ ✓ ✓
SDHyposmia ✓ ✓ ✓
SDInflammation · · ✓
SDMemory impairment · · ✓
SDPain in extremity ✓ ✓ ✓
SDParosmia ✓ ✓ ✓
SDRespiratory symptom · · ✓
SROHypogeusia ✓ ✓ ✓
SROHyposmia ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROTherapeutic response unexpected ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…